{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:53:49Z","timestamp":1790650429355,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,9,2]],"date-time":"2005-09-02T00:00:00Z","timestamp":1125619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Infectious respiratory diseases are transmitted to non-infected subjects when an infected person expels pathogenic microorganisms to the surrounding environment when coughing or sneezing. When the airway mucus layer interacts with high-speed airflow, droplets are expelled as aerosol; their concentration and size distribution may each play an important role in disease transmission. Our goal is to reduce the aerosolizability of respiratory secretions while interfering only minimally with normal mucus clearance using agents capable of increasing crosslinking in the mucin glycoprotein network.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We exposed mucus simulants (MS) to airflow in a simulated cough machine (SCM). The MS ranged from non-viscous, non-elastic substances (water) to MS of varying degrees of viscosity and elasticity. Mucociliary clearance of the MS was assessed on the frog palate, elasticity in the <jats:italic>Filancemeter<\/jats:italic> and the aerosol pattern in a \"bulls-eye\" target. The sample loaded was weighed before and after each cough maneuver. We tested two mucomodulators: sodium tetraborate (XL\"B\") and calcium chloride (XL \"C\").<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Mucociliary transport was close to normal speed in viscoelastic samples compared to non-elastic, non-viscous or viscous-only samples. Spinnability ranged from 2.5 \u00b1 0.6 to 50.9 \u00b1 6.9 cm, and the amount of MS expelled from the SCM increased from 47 % to 96 % adding 1.5 \u03bcL to 150 \u03bcL of XL \"B\". Concurrently, particles were inversely reduced to almost disappear from the aerosolization pattern.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The aerosolizability of MS was modified by increasing its cohesivity, thereby reducing the number of particles expelled from the SCM while interfering minimally with its clearance on the frog palate. An unexpected finding is that MS crosslinking increased \"expectoration\".<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2466-5-11","type":"journal-article","created":{"date-parts":[[2005,9,2]],"date-time":"2005-09-02T18:13:34Z","timestamp":1125684814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A new paradigm in respiratory hygiene: increasing the cohesivity of airway secretions to improve cough interaction and reduce aerosol dispersion"],"prefix":"10.1186","volume":"5","author":[{"given":"Gustavo","family":"Zayas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dimitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Zayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,2]]},"reference":[{"key":"37_CR1","volume-title":"Global Defense against the Infectious Disease Threat","author":"WHO","year":"2003","unstructured":"WHO: Global Defense against the Infectious Disease Threat. Edited by: Kindhauser MK. 2003, World Health Organization, Geneva"},{"key":"37_CR2","volume-title":"Infectious disease report","author":"WHO","year":"2002","unstructured":"WHO: Infectious disease report. 2002, World Health Organization, Geneva"},{"key":"37_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1378\/chest.125.3.1155","volume":"125","author":"R Somogyi","year":"2004","unstructured":"Somogyi R, Vesely AE, Azami T, Preiss D, Fisher J, Correia J, Fowler RA: Dispersal of respiratory droplets with open vs. closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome. Chest. 2004, 125: 1155-1157. 10.1378\/chest.125.3.1155.","journal-title":"Chest"},{"key":"37_CR4","volume-title":"Influenza pandemic preparedness plan. The role of WHO and guidelines for national or regional planning","author":"WHO","year":"1999","unstructured":"WHO: Influenza pandemic preparedness plan. The role of WHO and guidelines for national or regional planning. 1999, World Health Organization, Geneva"},{"key":"37_CR5","volume-title":"Global Plan to Stop TB, Chapter 1, p 27, Stop TB Partnership","author":"WHO","year":"2001","unstructured":"WHO: Global Plan to Stop TB, Chapter 1, p 27, Stop TB Partnership. 2001, WHO, Geneva"},{"key":"37_CR6","volume-title":"The WHO\/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance","author":"WHO","year":"2000","unstructured":"WHO: AntiTuberculosis Drug Resistance in the World. Report N\u00b0 2: Prevalence and Trends. The WHO\/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. 2000"},{"key":"37_CR7","volume-title":"Improving Patient Adherence to Tuberculosis treatment (1994)","author":"Centers for Disease Control & Prevention","year":"2002","unstructured":"Centers for Disease Control & Prevention: Improving Patient Adherence to Tuberculosis treatment (1994). 2002, National Center for HIV, STD and TB Prevention, Division of Tuberculosis Elimination"},{"key":"37_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/thorax.58.6.525","volume":"58","author":"AM Jones","year":"2003","unstructured":"Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK: Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax. 2003, 58: 525-527. 10.1136\/thorax.58.6.525.","journal-title":"Thorax"},{"key":"37_CR9","first-page":"385","volume":"52","author":"J Duguid","year":"1945","unstructured":"Duguid J: The numbers and sites of origin of the droplets expelled during respiratory activities. Edinburgh Med J. 1945, 52: 385-","journal-title":"Edinburgh Med J"},{"key":"37_CR10","first-page":"A706","volume":"157","author":"KP Fennelly","year":"1998","unstructured":"Fennelly KP, Martyny JW: Isolation of viable airborne Mycobacterium tuberculosis: a new method to study transmission. Am J Respir Crit Care Med. 1998, 157: A706-","journal-title":"Am J Respir Crit Care Med"},{"key":"37_CR11","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/S0169-409X(02)00156-4","volume":"54","author":"M King","year":"2002","unstructured":"King M, Rubin BK: Pharmacological approaches to discovery and development of new mucolytic agents. Advanced Drug Delivery Reviews. 2002, 54: 1475-1490. 10.1016\/S0169-409X(02)00156-4.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"37_CR12","first-page":"283","volume-title":"Chapter 7 of: Airway Secretion: Physiological Bases for the Control of Mucus Hypersecretion","author":"M King","year":"1994","unstructured":"King M, Rubin BK: Rheology of airway mucus: relationship with clearance function. Chapter 7 of: Airway Secretion: Physiological Bases for the Control of Mucus Hypersecretion. Edited by: Takishima T, Shimura S. 1994, New York: Marcel Dekker, 283-314."},{"key":"37_CR13","first-page":"181","volume-title":"Chapter 3.1 of: Respiratory Medicine","author":"SW Clarke","year":"2002","unstructured":"Clarke SW, King M: Respiratory defences: Physical defences. Chapter 3.1 of: Respiratory Medicine . Edited by: Gibson CJ. 2002, London: Saunders, 181-193. 3","edition":"3"},{"key":"37_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1155\/1999\/459084","volume":"6","author":"JG Zayas","year":"1999","unstructured":"Zayas JG, Rubin BK, York E, Lien D, King M: Bronchial mucus properties in lung cancer: relationship with site of lesion. Can Respir J. 1999, 6: 246-252.","journal-title":"Can Respir J"},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1152\/jappl.1985.58.6.1776","volume":"58","author":"M King","year":"1985","unstructured":"King M, Brock G, Lundell C: Clearance of mucus by simulated cough. J Appl Physiol. 1985, 58: 1776-1782.","journal-title":"J Appl Physiol"},{"key":"37_CR16","first-page":"191","volume-title":"Cilia, Mucus, and Mucociliary Interactions","author":"M King","year":"1998","unstructured":"King M, Festa E: Evolution of the frog palate model for mucociliary clearance 1970 \u2013 1997. Cilia, Mucus, and Mucociliary Interactions. Edited by: Baum GL. 1998, New York: Marcel Dekker, 191-201."},{"key":"37_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1152\/jappl.1990.69.2.424","volume":"69","author":"B Rubin","year":"1990","unstructured":"Rubin B, Ramirez O, King M: Mucus-depleted frog palate as a model for the study of mucociliary clearance. J Appl Physiol. 1990, 69: 424-429.","journal-title":"J Appl Physiol"},{"key":"37_CR18","volume-title":"Am J Respir Crit Care Med","author":"G Zayas","year":"2005","unstructured":"Zayas G, Valle JC, Alonso M, Alfaro H, Vega D, Bonilla G, Reyes M, King M: A new paradigm in respiratory hygiene: modulators of airway secretions to improve clearance. Am J Respir Crit Care Med. 2005, 171: [2005 Am Thoracic Soc Conf (abstract)]"},{"key":"37_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/BIR-1987-24611","volume":"24","author":"M King","year":"1987","unstructured":"King M: Role of mucus viscoelasticity in cough clearance. Biorheology. 1987, 24: 589-597.","journal-title":"Biorheology"},{"key":"37_CR20","first-page":"101","volume-title":"Chapter 3 of: Airway Secretion: Physiological Bases for the Control of Mucous Hypersecretion","author":"P Verdugo","year":"1994","unstructured":"Verdugo P: Molecular biophysics of mucin secretion. Chapter 3 of: Airway Secretion: Physiological Bases for the Control of Mucous Hypersecretion. Edited by: Takashima T, Shimura S. 1994, New York: Marcel Dekker, 101-121."},{"key":"37_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1201\/b14041-5","volume-title":"Therapy for Mucus-Clearance Disorders","author":"BK Rubin","year":"2004","unstructured":"Rubin BK, van der Schans CP: Outcomes for trials of mucoactive therapy. Therapy for Mucus-Clearance Disorders. Edited by: Rubin BK, van der Schans CP. 2004, New York: Marcel Dekker, 87-103."},{"key":"37_CR22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/BIR-1983-20214","volume":"20","author":"E Puchelle","year":"1983","unstructured":"Puchelle E, Zahm JM, Duvivier C: Spinnability of bronchial mucus: relationship with viscoelasticity and mucus transport properties. Biorheology. 1983, 20: 239-249.","journal-title":"Biorheology"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2466-5-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-5-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:20:13Z","timestamp":1630448413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/1471-2466-5-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1186\/1471-2466-5-11","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,2]]},"assertion":[{"value":"1 February 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}